Skip to main content
. 2024 Nov 21;11:1447716. doi: 10.3389/fmed.2024.1447716

Table 3.

Prospective studies reporting the prevalence of bronchiectasis among patients with inflammatory bowel disease (n = 6).

Reference Year Country IBD duration
Years
(unless specified)
Patients with
prevalent
IBD-BR (numerator)
Total IBD
Patients studied n(denominator)
Prevalence of IBD-BR in IBD (%) Chest imaging modality used Details on review of images and other notes
Mahadeva et al. (10) 2000 United Kingdom Mean 23.05 n = 13
(UC 11 CD 2)
n = 17
(UC 14 CD 3)
76% Research HRCT Two radiologists were blind to the clinical history. Some patients develop pulmonary symptoms within 2 years of colectomy surgery.
Desai et al. (1) 2011 India Mean 6.0
(range1-30)
n = 9 n = 95
(UC 83 CD 12)
9.47% Not reported Not reported. All patients diagnosed with IBD underwent inspiratory and respiratory HRCT.
Peradzynska et al. (21) 2012 Poland Mean 23.2 months (SD 20.68 months) n = 1 n = 50
(UC 25 CD 25)
2.00% Research HRCT Not reported. All patients underwent inspiratory and respiratory HRCT.
Songur et al. (16) 2002 Turkey Mean 3.6 (SD 2.7) n = 3 n = 36
(UC 23 CD 13)
8.33% Research HRCT Research physicians assessed patients imaging (blinding unspecified)
Yılmaz et al. (17) 2010 Turkey Mean 3 (SD 0.5) n = 2 n = 39
(UC 30 CD 9)
5.12% Research HRCT Research physicians blinded to clinical history. None of the patients had an occupational or family history of respiratory disease or atopy.
Tunc et al. (22) 2006 Turkey Mean7.2(SD6.5)
(range 0.1–35.0)
n = 5
(UC 3 CD 2)
n = 52
(UC 32 CD 20)
9.61% Research HRCT Not reported. All patients were included in the study with a questionnaire of respiratory symptoms, and patients with prior respiratory diseases were not included in the study.